What's New
Health Professional and Public Communication
KETOCONAZOLE - Risk of Potentially Fatal Liver Toxicity - Apotex Inc. and Teva Canada Limited
Ketoconazole use has been associated with liver damage including cases of death. Ketoconazole tablets are prescribed for the treatment of serious or life threatening fungal diseases and should not be used for common and superficial fungal infections.
Health Canada Health Professional Communication
Health Canada Public Communication
Health Professional and Public Communication
Intralipid - Missing French Label Information
Regarding Allergic Reactions to Egg-, Soya- or Peanut Protein - Baxter
Corporation
It is not recommended to use Intralipid, a fat
emulsion for intravenous infusion, if you have an allergy to egg-, soya- or
peanut protein or to any of the active or inactive ingredients. Patients or
guardians should inform health care professionals if they have a history of allergic
reactions to egg-, soya-, or peanut protein prior to starting Intralipid
therapy.
Health Canada Health Professional Communication
Health Canada Public Communication
Information Update
Health Canada’s review recommends codeine be used in
patients aged 12 and over
Health Canada has reviewed the safety of prescription
pain and cough medications containing codeine and is no longer recommending
their use in children less than 12 years of age. This recommendation is based
on very rare cases of serious side effects and deaths in children that have
been attributed to codeine, when given directly to a child, or to babies from
breast milk.
Health Canada Information Update
News Release / Communiqué de presse
NAPRA Supports Introduction of Private Member's Bill on the Disclosure of Drug Shortages / L'ANORP soutient le dépôt d'un projet de loi d'initiative parlementaire sur la déclaration des pénuries de médicaments
News Release / Communiqué de presse